Podcasts about principal investigators

Guest: Dr. Mekayla Storer is an Associate Professor at the University of Cambridge and a Principal Investigator at the Cambridge Stem Cell Institute. She discusses how mammalian digit tips regenerate after injury, focusing on the formation of the blastema and the cellular and molecular mechanisms that distinguish regeneration from scarring. She highlights the role of the extracellular matrix, tissue mechanics, and regenerative microenvironments in directing tissue repair, and explores how insights from digit tip regeneration may inform strategies to promote regeneration in other organs. Featured Products and Resources: Join us at ISSCR and discover breakthroughs, technologies, and clinical insights you can take back to your lab. Kick start your own journal club using our free toolkit equipped with downloadable checklists and templates. The Stem Cell Science Round Up Modeling EMT in Human Cells – Scientists have developed a human iPSC-based platform that enables standardized, multimodal analysis of epithelial-to-mesenchymal transition dynamics across 2D and 3D contexts. Modeling Persistent Ebola Infection – Human brain organoids reveal how persistent Ebola virus infection in neural cells drives long-term inflammation and viral evolution. Reducing Retinal Graft Rejection – Transient JAK inhibition reduces immune rejection of stem cell-derived retinal grafts and improves visual recovery. Enhancing Renal Regeneration – Targeting ENPP1 with a therapeutic antibody enhances regeneration and restores function after acute kidney injury. Photo Reference: Courtesy of Dr. Mekayla Storer Subscribe to our newsletter! Never miss updates about new episodes. Subscribe

Hi, I'm Jeff Ikler, host of the Cultivating Curiosity podcast. This summer, I'm periodically releasing mini-episodes of "Cultivating Curiosity." In about 10 minutes, I'll dive deeper into a key point from a previously broadcast evergreen episode. The content in these mini-episodes is designed to be readily applicable to your life or work. This week's mini-episode comes from a May 2023 interview with Dr. Alan Stern. Today, Dr. Stern is an aerospace executive and remains a planetary scientist. In 2015, he was the Principal Investigator on the historic New Horizons mission to Pluto. In that role, he had ultimate responsibility for the entire research project, overseeing its scientific, technical, and administrative aspects. The situation In 2015, after a nine-year journey, the New Horizons spacecraft was poised to complete its an historic flyby of Pluto. But success was not guaranteed. For the New Horizons' mission to be successful, all of the spacecraft's data-gathering instruments had to work flawlessly starting seven days before reaching its closest point to the planet and for at least two days after. All of the maneuvering of the seven data-gathering instruments – what they would look at, what they would measure – had to be preprogrammed into the craft's computer. There was simply no way someone back at Mission Control could drive the spacecraft in real time, because by 2015 New Horizons was three billion miles from Earth. A signal traveling at the speed of light would take 4.5 hours to reach the speeding spacecraft. In that amount of time, whatever Mission Control had been directing the spacecraft to photograph or measure would likely have passed. But preprogramming didn't guarantee success either. New Horizons, traveling at 35,000 miles an hour, had to reach a specific point in space within a nine-minute window, or "the box," as the team referred to it. If the craft were early or late to that point, the computer would be directing the instruments to look at or measure something during the critical flyby period that wasn't centered in their field of view – or potentially not there at all. And there would be no time to recalibrate them. Orbiting Pluto for a redo was out of the question because the spacecraft didn't have the necessary fuel to execute such a move. Orbiting Pluto wasn't even in the mission plan. If the box were missed, the potential to collect data would be lost. The mission would have failed. A grace period of only nine minutes. 540 seconds. After three billion miles. And nine years. The good news is that Mission Control scientists were carefully monitoring the spacecraft as it approached the ideal central point and calculated that it was less than two minutes off – way inside the nine-minute box. Everyone in Mission Control breathed a sigh of relief. But what if we…? Scientists and engineers are, however, perfectionists, so the question quickly arose, "Do we make a correction? Do we scratch back a few more important seconds to make sure our instruments are pointing where we want them to point?" Days before the critical flyby, there was still time to do so. It was a tempting proposition. Dr. Stern picks up the story. Once we got in the box, the navigation teams recommended that we do one more engine firing to really put it in the middle of the box. And we had an analysis done that showed that if we didn't change anything if we stayed where we were, didn't go to the middle of the box but we're just in the box, we would get every single scientific observation One that we had set out to do. And yet they were recommending, and in fact, the engineering and science teams, were recommending that we just nail it, we go right down the middle of the pike. And I rejected that as the leader of the mission. Because at that point, we were going to get everything we came for. And while we might have done a few things a little bit better, the risk that that engine burn might have gone haywire, or sent the spacecraft into some fetal position where it needed help from Mama back on Earth before or we could carry out the flyby was real. And I didn't want to take any risk. Once we were in the box. You know, there's an old saying Better is the enemy of good knife. Yeah, right. It was good enough. And as you've seen from the results, we really nailed it. So I'm glad that we, we backed away from that, because it looks to me like more risk than reward, To summarize, as the mission leader, Dr. Stern gathered everyone on his team together to review the navigation calculations, and then took three powerful steps: 1. Stern asked each of his team members to voice their opinion on the wisdom of making the correction. One by one, around the table, each leader of a critical aspect of the program voiced "Go," recommending the correction. 2. Stern waited and took notes until everyone had the opportunity to voice his or her opinion. He then made the decision: "No go." 3. He then asked a critical question, "Is there a must-do reason to make the correction when we're already safely within the box?" He went back around the room and asked each section leader to respond. After hearing from everyone, Stern stood with his original "No go." It was simply not worth the risk of introducing a potential programming error this late in the game. New Horizons soon flew past Pluto at 35,000 miles an hour, a mere 7,500 miles above the dwarf planet's surface. As the spacecraft began to "phone home" amazing images and other data, it was clear that New Horizons – the first mission to Pluto – was an unqualified success. "Good enough" was truly good enough. The idea Leaders typically struggle with three questions in scenarios like the one before the New Horizons team, and they do so because they feel "All eyes are on me." • Do they feel they need to make the immediate call without input because they're the leader, or do they ask to hear from all members of their team on the critical question? • Do they speak first because they're the leader, or do they weigh input from the team and speak last? And finally, • Do they push for "better," or do they stand pat when there is evidence that "good enough" is truly good enough? Here's Dr. Stern's further rationale for the process. I always speak last. As the mission leader, I'm a firm believer that, well, I might set the table, I might start a meeting off, here are our objectives, here's what we should consider that the final gonna go on my part should be considered one, having heard from all the experts that know more than me about each individual area, my job is to go broad, and make sure that the mission carries out all of his objectives. And their job is to go deep, and make sure that each little piece is operating properly. So I was last in that poll. And I did reject what was a unanimous decision by everyone else. And it was a little lonely, but you know what, I was confident in it. And it worked out just fine. Dr. Melissa Hughes, a neuroscience geek researcher and author of Happier Hour with Einstein, Another Round, reinforces Dr. Stern's steps as a meaningful way to avoid "groupthink," which she defined as "a psychological phenomenon that happens when people in a group willingly or unconsciously commit to decisions they don't necessarily agree with to avoid creating emotional tension or conflict with their colleagues." In Dr. Stern's case, no one on his team wanted to be the only "No go" and buck the "groupthink." The consequences of groupthink, as Dr. Hughes describes, can be significant: "When people…put harmony and cohesion above the critical evaluation and analysis of the outcome, they stifle their thoughts, refrain from asking the hard questions and avoid exposing potential pitfalls. This often leads to irrational or problematic decisions." In New Horizons' case, the consequences of groupthink could have been disastrous. A program note: If you're a space geek like I am, I've included a couple of illustrations of the mission in the shownotes on my website.

Episode Topic: Fr. Ted Said: Cultivating HopeIn his inaugural address, University President Rev. Robert A. Dowd, C.S.C., called us to be “sustainers of hope and builders of bridges.” But in a world where optimism often feels in short supply, where do we find the inspiration to keep nurturing the good? Plant those seeds through a revitalizing experience where you can pause, exhale, and allow your spirit to blossom. Come hear this calling echo in powerful, personal stories from Notre Dame alumni and faculty who are living examples of what it means to cultivate hope—just like Fr. Ted.Featured Speakers:Dolly Duffy '84, Executive Director, Notre Dame Alumni Association, University of Notre DameMichael Schreffler, Art History Professor, Director of the Notre Dame Arts Initiative, Associate Dean for the Arts, College of Arts and Letters, University of Notre DameMike Brown '01, Former Notre Dame Leprechaun, Speaker, Author, Founder of SoulstirGlynnis Garry Bann, M.D. '11, Assistant Professor, Principal Investigator, Departments of Internal Medicine and Molecular Biology at UT Southwestern Medical CenterJennifer Burke Lefever '98 M.A., '00 Ph.D., Managing Director, Wilma and Peter Veldman Family Psychology Clinic, University of Notre DameRev. Pete McCormick, C.S.C., '06 M.Div., '15 MBA, Assistant Vice President of Campus Ministry, University of Notre DameJ. Martin (Marty) Regan, Jr. '76, Senior Staff Attorney, City of Memphis, Lewis ThomasonThis podcast is a part of the ThinkND Series titled Reunion 2026.Thanks for listening! The ThinkND Podcast is brought to you by ThinkND, the University of Notre Dame's online learning community. We connect you with videos, podcasts, articles, courses, and other resources to inspire minds and spark conversations on topics that matter to you — everything from faith and politics, to science, technology, and your career.Learn more about ThinkND and register for upcoming live events at think.nd.edu.Join our LinkedIn community for updates, episode clips, and more.

On The Space Show for Wednesday, 17 June 2026:Australian Space Research Conference: * Iron Making on Mars with Dr Deddy Nababan, Postdoctoral Fellow at CSIRO Mineral Resources and a Swinburne University alum.  * Studying the Sun with balloons launched by a student team with Joseph George, Monash High Altitude Balloon team, Monash University, Clayton. Artemis Lunar Science:Artemis II — Looking for electrostatic levitation of lofted Lunar dust and impact flashesArtemis I — The early results of BioSentinel with Dr Sergio Santa Maria, Principal Investigator of Space Bio Sciences at the NASA Ames Research Centre. Lunar Science in the Artemis Era: The Space Show series in which we discuss the scientific investigation of the Moon and its environment in the Artemis era. (Episode 01 is here: https://open.spotify.com/episode/22gtgYHWhm9fJNJnaPJVw5)Turn Back Time: * Gemini 9 and the ‘Angry Alligator'. (Inserts courtesy VOA) * The OGO 3 satellite launched. (Insert courtesy VOA) * An Able-Star rocket stage explosion becomes the first major space debris event with 321 tracked pieces. * United Nations 'Moon Treaty' negotiations begin. (Inserts courtesy VOA)

An Garda Síochána have announced that their pilot programme for the use of tasers will be extended through the rest of the year and expanded to include Limerick. Is the extension and use of tasers welcome? Joining Anton this morning to discuss was Retired Garda Sergeant and Local Peace Commissioner in Donegal, Christy Galligan, and Dr Lucy Michael, Principal Investigator at Lucy Michael Research, Training and Consultancy.

An Garda Síochána have announced that their pilot programme for the use of tasers will be extended through the rest of the year and expanded to include Limerick. Is the extension and use of tasers welcome? Joining Anton this morning to discuss was Retired Garda Sergeant and Local Peace Commissioner in Donegal, Christy Galligan, and Dr Lucy Michael, Principal Investigator at Lucy Michael Research, Training and Consultancy.

What if a cancerous tumour could be destroyed without a single incision, stitch or scar? A Singapore grandfather waiting for a liver transplant has become one of the first patients in Southeast Asia to undergo a breakthrough treatment called histotripsy - a technology that uses focused sound waves to destroy a liver tumour. Could this be a glimpse into the future of medicine, where cancer treatment becomes less invasive? Hosted by Michelle Martin, this episode explores the science, the human story and what innovations like histotripsy could mean for longevity and the future of cancer care. Send this episode onto someone who needs a boost of hope. Guest: Prof Brian Goh, Head of Department of Hepato-pancreato-biliary and Transplant Surgery, SGH & NCCS, and Principal Investigator of the HALT Study.See omnystudio.com/listener for privacy information.

Marco Damiani, Chief Executive Officer of AHRC New York City (AHRC NYC), joins the DEP RRTC's Let's Get to Work podcast hosted by Dr. Peter Blanck, University Professor and Chairman of the Burton Blatt Institute at Syracuse University and Principal Investigator of the DEP RRTC. Drawing on decades of experience supporting people with disabilities, Marco discusses his journey from working as a direct support professional to leading one of the largest organizations supporting people with intellectual and developmental disabilities in the U.S. He highlights the movement from institutionalization to community-based supports and services and the importance of self-advocacy, self-determination, and Supported Decision-Making. Marco and Peter also emphasize employment as a way to advance independence and community participation. Using AHRC NYC's nationally recognized initiatives as examples, they show how meaningful, competitive work benefits people with disabilities, employers, communities, and the broader economy.

Irish children became less accomplished in reading and mathematics after the Covid-19 pandemic, with children from poorer backgrounds falling further behind their better-off peers.That is according to new research from UCD's Children's School Lives study.Professor Dympna Devine, Principal Investigator for Children's Student Lives at UCD and Professor of Education, Society and Critical Childhood Studies, joined Anton to discuss the findings.

Irish children became less accomplished in reading and mathematics after the Covid-19 pandemic, with children from poorer backgrounds falling further behind their better-off peers.That is according to new research from UCD's Children's School Lives study.Professor Dympna Devine, Principal Investigator for Children's Student Lives at UCD and Professor of Education, Society and Critical Childhood Studies, joined Anton to discuss the findings.

Dr. Purvi Sevak, Senior Director of Mathematica's Disability Practice, joins the DEP RRTC's Let's Get to Work podcast hosted by Dr. Peter Blanck, University Professor and Chairman of the Burton Blatt Institute at Syracuse University and Principal Investigator of the DEP RRTC. Dr. Sevak discusses her path from an undergraduate student studying health policy to her work at Mathematica, the evolution and importance of disability employment policy, and her research with the DEP RRTC examining how local infrastructure affects employment opportunities for people with disabilities. Drawing on both professional and personal experiences, Dr. Sevak highlights the importance of disability employment policy to the broader economy. “Making sure that everyone who wants to work can work and contribute is important,” she states. “If people with disabilities are employed and earning more than they could be making on SSI, they're going to be spending more money and just contributing to the local economy, buying more things, renting apartments.”

Lindy Elkins-Tanton, Principal Investigator of Psyche, joins Jake and Anthony to talk about Leadership on big NASA missions in her new book Mission Ready. Topics Off-Nominal - YouTube Episode 244 - Helen from Everywhere (with Lindy Elkins-Tanton) - YouTube Mission Ready by Lindy Elkins-Tanton | Hachette Book Group NASA's Psyche Mission Aces Mars Flyby, Targets Metal-Rich Asteroid | NASA Jet Propulsion Laboratory (JPL) Psyche Mission Gallery - Images & Videos | Psyche Mission Psyche IRB (PDF) Follow Off-Nominal Subscribe to the show! - Off-Nominal Support the show, join the Discord Off-Nominal (@offnom) / Twitter Off-Nominal (@offnom@spacey.space) - Spacey Space Follow Jake WeMartians Podcast - Follow Humanity's Journey to Mars WeMartians Podcast (@We_Martians) | Twitter Jake Robins (@JakeOnOrbit) | Twitter Jake Robins (@JakeOnOrbit@spacey.space) - Spacey Space Follow Anthony Main Engine Cut Off Main Engine Cut Off (@WeHaveMECO) | Twitter Main Engine Cut Off (@meco@spacey.space) - Spacey Space Anthony Colangelo (@acolangelo) | Twitter Anthony Colangelo (@acolangelo@jawns.club) - jawns.club

This episode of the Mind the Kids podcast features Dr. Joanne Park, clinical psychologist and Principal Investigator of the Parenting Resilient Kids (Park) Lab at Mount Royal University, Canada. Hosted by Clara Faria, the conversation explores emerging research on “climate worry” in early adolescence, drawing on Dr. Park's recent publication in Child and Adolescent Mental Health.Dr. Park examines whether concerns about climate change represent a distinct psychological construct or are simply an extension of generalised anxiety. The discussion unpacks the difference between affective climate worry—emotional responses to climate change—and cognitive climate worry, which reflects more developed fears about future impact. Importantly, the findings suggest that climate worry is not only common among younger adolescents but may also have unique associations with wellbeing, independent of general anxiety.The episode also highlights key developmental, social, and gender-related factors shaping how young people experience climate-related distress. Dr. Park discusses why girls and gender-diverse adolescents may report higher levels of climate worry, and considers how clinicians, educators, and parents can respond without over-pathologising what may be a rational reaction to the climate crisis.This conversation is essential listening for clinicians, researchers, and educators interested in child and adolescent mental health, particularly those working with anxiety, emotional development, and the psychological impact of global challenges. It also offers practical insight into how to support young people in managing climate-related concerns through adaptive coping and resilience-building strategies.Read the CAMH journal paper ‘Prevalence, conceptual distinctiveness, and cross-sectional correlates of climate worry in Canadian adolescents' - https://doi.org/10.1111/camh.70076Joanne L. Park, Audrey-Ann Deneault, Brae Anne McArthur, Suzanne Tough, Sheri MadiganFirst published: 18 February 2026Get a free CPD/CME certificate for listening to this podcast by registering for a FREE ACAMH Learn account at https://bit.ly/4fF4BBWVisit https://www.acamh.orgFacebook and LinkedIn search / ACAMHInstagram https://www.instagram.com/assoc.camhBluesky https://bsky.app/profile/acamh.bsky.socialX https://x.com/acamh

In episode 78 of Going anti-Viral, Dr Rajesh T. Gandhi joins host Dr Michael Saag to discuss the process of guidelines development. Dr Gandhi is a Professor of Medicine at Harvard Medical School and Principal Investigator and Co-Director of the Harvard University Center for AIDS Research (CFAR). Dr Gandhi is the Vice-Chair of the ACTG, Vice-Chair of the Infectious Diseases Society of America COVID-19 Treatment Guidelines Panel, Chair of the International Antiviral Society-USA Panel on Antiretroviral Drugs for Treatment and Prevention of HIV in Adults, and the Lead Editor for Infectious Diseases, NEJM Clinician. Dr Gandhi and Dr Saag explore the intricate process of developing HIV treatment guidelines, including evidence review, panel selection, and updates on new topics like transgender care and substance use disorders. They discuss how guidelines are created, their impact on clinical practice, and future directions in HIV care.0:00 – Introduction 1:54 – The purpose and impact of guidelines4:00 – Panel composition and selection process6:00 – Guideline structure and key updates12:34 – Emerging topics: transgender care and transplant medicine14:31 – Substance use disorders and treatment innovations16:03 – Evidence-based recommendations and their strength22:07 – Guidelines development process and team dynamics24:42 – Living guidelines versus published documents28:41 – Closing thoughts and future directionsResources: Going-anti-Viral: Episode 32 - Update on the New Antiretroviral Therapy Guidelines - Dr Rajesh GandhiYouTube:  https://youtu.be/G7FQTInz-dY Apple Podcasts:  https://podcasts.apple.com/us/podcast/episode-32-update-on-the-new-antiretroviral-therapy/id1713226144?i=1000678818027 __________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections.Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

Wie kam es zum Ausbruch des Hantavirus in Südamerika? Um welchen Stamm des Virus handelt es sich und was hat das alles mit der Lüftungssituation auf Kreuzfahrtschiffen zu tun. Ein Podcast von Pragmaticus.Das Thema:Es waren Meldungen, die an die Corona-Zeit erinnerten. Auf dem Kreuzfahrtschiff Hondius starb Anfang Mai ein Mann an einer Variante des Hantavirus, wenig später seine Frau. Das Schiff wurde in Quarantäne gesetzt, die WHO eingeschalten und schnell hatten Virologen eruiert, dass es sich um die Andes-Variante aus der Familie der Hantaviren handelt.Seine Besonderheit: Es springt nicht nur von Nagetieren auf Menschen, sondern dann auch von Mensch zu Mensch. „Es ist eine Neuweltvariante und kommt immer wieder in Südamerika vor“, resümiert der Viren-Experte Florian Krammer, der den Hantaviren seine Berufswahl zu verdanken hat. In seiner Heimat in Steiermark werden immer wieder Menschen infiziert, wenn sie „zum Beispiel Garagen auskehren und auf diese Weise den pulverisierten Kot von Rötelmäusen einatmen“, erzählt Krammer. Einige von ihnen erkrankten schwer, andere nicht.Mittlerweile forscht Krammer an Medikamenten und Impfstoffen für Erkrankte, eine Frage der finanziellen Mittel. Aber es geht auch um die Infektionsgefahr etwa auf Kreuzfahrtschiffen. Ihn als Virologe brächten keine zehn Pferde auf so ein Schiff, zu groß ist dort die Infektionsgefahr. Unser Gast in dieser Folge: Florian Krammer hat an der Universität für Bodenkultur in Wien studiert und seine Postdoc-Ausbildung im Labor von Peter Palese an der Icahn School of Medicine at Mount Sinai, New York absolviert. Dort beschäftigte er sich vor allem mit dem Influenzavirus. Im Jahr 2014 wurde er unabhängiger Principal Investigator und ist derzeit Mount-Sinai-Stiftungsprofessor für Vakzinologie an der Icahn School of Medicine at Mount Sinai. Außerdem ist Krammer seit 2024 Professor für Infektionsmedizin am Ignaz-Semmelweis-Institut der Medizinischen Universität Wien. Er konzentriert sich auf das Verständnis der Mechanismen von Interaktionen zwischen Antikörpern und viralen Oberflächenglykoproteinen und auf die Umsetzung dieser Arbeit in neuartige, breit schützende Impfstoffe und Therapeutika. Sein Hauptfokus ist das Influenzavirus, aber er arbeitet auch an Coronaviren, Flaviviren, Hantaviren, Filoviren und Arenaviren. Er hat mehr als 400 Arbeiten zu diesen Themen veröffentlicht.Dies ist ein Podcast von Der Pragmaticus. Sie finden uns auch auf Instagram, Facebook, LinkedIn und X (Twitter).

In this episode of HPNA Palliative Perspective, we're joined by Betty Ferrell—Editor of the Journal of Hospice & Palliative Nursing (JHPN), nurse, and internationally recognized researcher. As the leader of the End-of-Life Nursing Education Consortium, she brings a unique perspective shaped by decades of connection with hospice and palliative care nurses across the U.S. and around the world.  Now in her 49th year in nursing—beginning in oncology and entering hospice as it emerged in the United States—Dr. Ferrell reflects on the remarkable growth of the field and where we stand today.  At the heart of this conversation is the idea of a “professional home.” Drawing on the foundational work of pioneers like Florence Wald and Cicely Saunders, she highlights the enduring importance of interprofessional, whole-person care—and the need to stay grounded in those values as the field evolves.  In a time that can feel complex and demanding, this episode offers a clear message: you don't have to do this work alone. Finding your people, building community, and staying connected—through colleagues and organizations like the Hospice and Palliative Nurses Association—are essential to sustaining both practice and purpose.  A thoughtful and reassuring conversation about belonging, connection, and the future of hospice and palliative nursing.      Betty Ferrell, RN, PhD, MA, CHPN®, FAAN, FPCN® Betty Ferrell, RN, PhD, MA, CHPN®, FAAN, FPCN® has been in nursing for 48 years and has focused her clinical expertise and research in pain management, quality of life, and palliative care. Dr. Ferrell is the Director of Nursing Research & Education and a Professor at the City of Hope Medical Center in Duarte, California. She is a Fellow of the American Academy of Nursing and she has over 500 publications in peer-reviewed journals and texts. She is Principal Investigator of the “End-of-Life Nursing Education Consortium (ELNEC)” project. She directs several other funded projects related to palliative care in cancer centers and QOL issues. Dr. Ferrell was Co-Chairperson of the National Consensus Project for Quality Palliative Care. Dr. Ferrell completed a Masters degree in Theology, Ethics and Culture from Claremont Graduate University in 2007. She has authored 12 books including the Oxford Textbook of Palliative Nursing (5th Edition, 2019) published by Oxford University Press. She is co-author of the text, The Nature of Suffering and the Goals of Nursing published by Oxford University Press (2nd Ed, 2023) and Making Health Care Whole: Integrating Spirituality into Patient Care (Templeton Press, 2010). In 2013 Dr. Ferrell was named one of the 30 Visionaries in the field by the American Academy of Hospice and Palliative Medicine. In 2019 she was elected a member of the National Academy of Medicine. In 2021 Dr. Ferrell received the Oncology Nursing Society Lifetime Achievement Award and she was inducted as a “Living Legend” by the American Academy of Nursing   Brett Snodgrass, DNP, FNP-C, ACHPN®, FAANP Dr. Brett Snodgrass has been a registered nurse for 28 years and a Family Nurse Practitioner for 18 years, practicing in multiple settings, including family practice, urgent care, emergency departments, administration, chronic pain and palliative medicine. She is currently the Operations Director for Palliative Medicine at Baptist Health Systems in Memphis, TN. She is board certified with the American Academy of Nurse Practitioners. She is also a Fellow of the American Association of Nurse Practitioners and an Advanced Certified Hospice and Palliative Nurse. She completed a Doctorate of Nursing Practice at the University of Alabama – Huntsville. She is a nationally recognized nurse practitioner speaker and teacher. Brett is a chronic pain expert, working for more than 20 years with chronic pain and palliative patients in a variety of settings. She is honored to be the HPNA 2025 podcast host. She is married with two daughters, two son in laws, one grandson, and now an empty nest cat. She and her family are actively involved in their church and she is an avid reader.

Photo by Sergiu Vălenaș on Unsplash Wars and other life circumstances can result in children being orphaned and neglected. Around the world, including in our own community, grandparents are becoming caregivers for their grandchildren, but often with little support. Someone who has been studying this issue is Dr. Schola Matovu, a gerontological nurse scientist, Assistant Professor and Director of Global Learning and Engagement at the University of Utah College of Nursing, where she also serves as the Principal Investigator for the Matovu Research Lab. She is a Fellow in the Betty Irene Moore Fellowship for Nurse Leaders and Innovators. HealthCetera host Diana J. Mason, PhD, RN, talked with Dr. Matovu about her work on grandparents as caregivers for their grandchildren. This interview first aired on HealthCetera in the Catskills on WIOX Radio on April 29, 2026. The post Grandparents Becoming Caregivers appeared first on HealthCetera.

Neal Shaw joins host Ron Aaron and co-host Carol Zernial to talk about the lack of caregiving training caregivers receive and caring for the older population on this edition of Caregiver SOS. About Neal Neal K. Shah is a healthcare researcher focused on caregiving for the aging population. He is an NIH-funded Principal Investigator on the YayaGuide AI for Caregiver Training project that he started at Johns Hopkins. Neal is also CEO of CareYaya, a social enterprise providing affordable eldercare and bringing thousands of college students into the caregiving workforce. He serves on North Carolina's Steering Committee on Aging. Neal previously managed a $250 million hedge fund in New York City in his mid-30s, when he suddenly became a family caregiver through dementia and cancer, which led him to shift the focus of his career and work to better supporting caregivers. He is active on social media across Instagram and LinkedIn with an audience of over 250,000 caregivers across America. Hosts Ron Aaron and Carol Zernial, and their guests talk about Caregiving and how to best cope with the stresses associated with it. Learn about "Caregiver SOS" and the "Teleconnection Hotline" programs.See omnystudio.com/listener for privacy information.

In this episode of the NTI PodTalk, Dianne chats with NTI instructor, Megan Grover. They discuss chronic stress, burnout, and the role herbal medicine can play in supporting resilience and recovery. Megan explains the science behind adaptogens, like ashwagandha, and discusses how chronic stress impacts the nervous system, immune health, sleep, hormones, and digestion. They also discuss the realities of modern burnout culture, and practical strategies for supporting emotional regulation and nervous system balance. In today's fast-paced, high stress world, the information in this episode is so relevant and beneficial for anyone. Tune in to learn how to build resilience with herbs and reduce your stress. About Megan Grover:Megan Grover is a nutrition scientist and educator, based in New York City. With a Master of Medical Science in Human Nutrition from the University of Sheffield and over a decade of experience bridging science, education, and public health, Megan has built her career on translating complex nutritional science into actionable strategies. As the former Director of Education and Research at a growing wellness company, Megan led clinical research initiatives, served as the Principal Investigator on IRB-approved studies, and supported product development. She also created and oversaw the nutrition continuing education department for integrative nutrition coaches and dietitians, and managed all science-facing content across the organization.Megan teaches multiple nutrition science classes at NTI and previously served as a full-time professor of human anatomy, physiology, and nutrition at the university level. She started MBG Wellness to address a critical gap she observed throughout her career: driven executives and professionals were experiencing burnout despite outward success. Through corporate wellness programming, Megan delivers the nutrition education, strategic support, and science-backed interventions that enable teams to sustain performance without sacrificing wellbeing.Connect with Megan:MBG WellnessInstagramSubstackLinkedIn**Timestamps for the topics discussed can be found on this episode's NTI PodTalk page,Are you ready to start your journey as a Nutrition Therapist Master? To learn more about NTI's Nutrition Therapist Master Certification, visit ntischool.com for more information, or call 303-284-8361 to speak with our admissions team.This discussion is not intended to provide Medical Nutrition Therapy, nor in any way imply that Nutrition Therapists who graduate from NTI are qualified to provide Medical Nutrition Therapy. The scope of practice for graduates of NTI is to deliver therapeutic nutrition guidance to our clients which helps support their natural biology to achieve optimal function in whatever wellness path they are on.

Leading Irish neuroimmunologist Prof. Denise Fitzgerald has been awarded €6.26 million Research Professorship funding from Research Ireland to investigate ways that ageing affects how the immune system helps repair brain tissue in illnesses such as Multiple Sclerosis (MS). The funding means that over the next five years, Prof. Fitzgerald – who has, until now, been based exclusively in Queen's University Belfast – will lead a research team of ten based in Trinity College Dublin and partnering with FutureNeuro Research Ireland Centre for Translational Brain Science, St James's Hospital and Beaumont Hospital to discover why our immune cells become less able to coax brain stem cells to repair damage as we age. This research combines immunology, neuroscience and regenerative biology to tackle this complex problem. Prof. Fitzgerald said: "This ambitious programme of research will uncover new insights into fundamental changes in the older immune system that has a knock-on effect on brain repair. This new knowledge can then be used to develop pioneering regenerative treatment for MS and other neurological conditions. To speed this up, we are embedding research into new clinical trials led by consultant neurologist, Hugh Kearney. "This will increase the opportunities for people with MS in Ireland to access experimental treatments early, as well as to co-produce research with us as key public members of the research programme. Through this neuroimmunology research programme we will train the next generation of scientists, doctors and health professionals, side-by-side, in partnership with the public." Commenting on the announcement, Dr Diarmuid O'Brien, CEO of Research Ireland commented: "Research Ireland is pleased to support Prof. Fitzgerald's critically important work over the next five years, with the investment facilitating an additional 11 research positions, comprising postdocs, PhDs, research assistants and senior research fellows. Funding excellent research talent is a key part of our recently launched strategy, as is addressing Ireland's opportunities and challenges in areas such as public health. I look forward to seeing the outputs and impact of Prof. Fitzgerald's endeavours over the coming years." Through this appointment, Prof. Fitzgerald will divide her role between Trinity College Dublin and Queen's University Belfast, promoting all-island collaboration across neuroimmunology and other research areas. She will be an investigator at FutureNeuro, the RCSI-based Research Ireland Centre that aims to translate breakthroughs in understanding of brain structure and function to transform the patient journey for people with neurological diseases. She also brings extensive international collaboration with world-leading experts at Cambridge University, University College London, the University of Toronto, the Institute of Neuroscience – Alicante, the Wellcome Sanger Institute and Maynooth University. Prof. Colin Doherty, head of the School of Medicine in Trinity and a Principal Investigator with FutureNeuro said: "I have known Denise for some time and have marvelled at the quality of her research into one of the great and challenging areas of medical science. We are delighted that she will be leading a team here in Trinity while retaining her links with Queen's, strengthening all-island collaboration in neuroimmunology and creating exciting new opportunities across the wider FutureNeuro research network." See more stories here. Irish Tech News are Ireland's No. 1 Online Tech Publication and often Ireland's No.1 Tech Podcast too. You can find hundreds of fantastic previous episodes and subscribe using whatever platform you like via our Anchor.fm page here: https://anchor.fm/irish-tech-news If you'd like to be featured in an upcoming Podcast email us at Simon@IrishTechNews.ie now to discuss. Irish Tech News have a range of services available to help promote your business. Why not drop us a line at Info@IrishTechNews.ie now to find...

Send us Fan MailDrowning is the leading cause of death for children ages 1 to 4 in multiple countries - yet it receives only a fraction of the attention of other public health crises. Why?Acacia Landfield is Associate Director, Principal Investigator, and Director of Policy & Implementation Science at The Drowning Research & Injury Prevention Policy Institute ( DRIPPI - https://www.drippi.org/ ), a multidisciplinary nonprofit consortium focused on reducing drowning deaths through research, education, systems thinking, and policy innovation.Acacia brings together an unusually broad background spanning public health, international diplomacy, education, implementation science, and aquatic safety. A lifelong swim coach and water safety educator, she has spent more than 25 years working across injury prevention, public policy, and community education, with a mission to address one of the world's most overlooked public health crises: childhood drowning.Acacia's work focuses on what she calls “universal basic aquatic competency” - the idea that early, gentle, developmentally informed water exposure can fundamentally change drowning outcomes across entire populations. Her research explores everything from breathing mechanics and motor learning in the water to the unintended downstream effects of flotation devices and inequities in aquatic infrastructure.Acacia is also helping reframe drowning prevention as part of a much larger conversation around climate resilience, disaster preparedness, urban planning, and health equity. As a 2024 Presidential Road Safety Scholar with the American Public Health Association, and an active contributor to climate and disaster preparedness initiatives, she is pushing for drowning prevention to be treated not as a niche issue, but as a core pillar of public health policy worldwide.Before co-founding DRIPPI and launching her research initiative SASE, Acacia held leadership and strategy roles at Massachusetts Institute of Technology, Harvard University, and the U.S. Department of State, where she worked on international education, diplomacy, and policy initiatives across multiple countries and sectors.Acacia holds degrees from Yale University and San José State University, is completing her MPH, and plans to pursue a DrPH focused on implementation science and injury prevention.Today, we'll explore why drowning remains one of the leading causes of death for children worldwide, why many current prevention models may be incomplete, and how a systems-level rethink of aquatic literacy could potentially save tens of thousands of lives each year.#DrowningPrevention #WaterSafety #AquaticLiteracy #Swimming #PublicHealth #ClimateResilience #ChildSafety #AquaticCompetency #DRIPPI #AcaciaLandfield #InjuryPrevention #SwimSafety #Aquatics #GlobalHealth #ClimateChange #ImplementationScience #AquaticEducation #SwimmingLessons #Parenting #HealthPodcast #Longevity #BrainHealth #DisasterPreparedness #HealthInnovation #WaterCompetencySupport the show

In this episode of Transmission Interrupted, host Jill Morgan sits down with Dr. Gaby Frank, internist and director of the Special Pathogens Center at Johns Hopkins, to provide clarity and insight on the current hantavirus outbreak. The conversation kicks off by demystifying essential public health terms like "isolation" and "quarantine," explaining their definitions and uses in the context of infectious diseases in the U.S. Jill and Dr. Frank then dive into the science behind hantavirus, specifically the unique Andes virus strain in Argentina and its rare but notable potential for human-to-human transmission, a distinction setting it apart from the many other hantavirus strains found throughout the Americas. Listeners will gain a clearer understanding of how hantavirus is typically contracted—primarily from aerosolized rodent droppings rather than person-to-person transmission—and the actual risks associated with exposure. The episode highlights findings from a long-term study in Chile, which revealed only 3.3% of close contacts developed the disease, with greatest risk among household and romantic partners. Jill and Dr. Frank dispel some of the fear and misinformation circulating about hantavirus, stressing that while severe cases can occur, the general public's risk remains very low. Through expert perspective and practical advice, this episode underscores the importance of strategic preparedness and ongoing research, empowering listeners with the knowledge they need to stay safe and informed. Guest Maria (Gaby) Frank, MD, FACP, SFHM Professor of Medicine, PAR, Johns Hopkins University Director, Johns Hopkins Special Pathogens Center Dr. Frank is a hospitalist. Professor of Medicine PAR, and the Director of Johns Hopkins' Special Pathogens Center Johns Hopkins Hospital in Baltimore, MD, one of the 13 Regional Emerging Special Pathogen Treatment Centers (RESPTCs). The Johns Hopkins Hospital (JHH) is a premier 1000-bed non-profit academic medical center within the larger Johns Hopkins Health System, one of the leading health care systems in the United States. The 5-hospital health system in the Baltimore-Washington area has 2513 beds (354 intensive care unit beds) and serves approximately 7 million people. JHH provides a full range of clinical services including specialty care for both adults and pediatric patients. The Johns Hopkins Hospital was ranked number one in the nation by U.S. News & World Report for 22 years of the survey's 30-year history. Before joining Johns Hopkins, Dr. Frank was the Medical Director of the biocontainment unit at Denver Health and Hospital Authority. In her role as the medical director of BCU, she served as the site Principal Investigator for the NIH-sponsored ACTT trial and is actively involved in the National Emerging Special Pathogen Training and Education Center (NETEC) and Special Pathogens Research Network (SPRN). Dr. Frank received her medical diploma from the University of Buenos Aires in Buenos Aires, Argentina, and completed a residency in Internal Medicine and another in Emergency Medicine in Argentina. She immigrated to the U.S. in 2004, where she completed another Internal Medicine Residency at the University of Colorado, joining as faculty after graduation. Her areas of interest include emergent special pathogens, and disaster preparedness and response. Host Jill Morgan, RN Emory Healthcare, Atlanta, GA Jill Morgan is a registered nurse and a subject matter expert in personal protective equipment (PPE) for NETEC. For 35 years, Jill has been an emergency department and critical care nurse, and now splits her time between education for NETEC and clinical research, most of it centering around infection prevention and personal protective equipment. She is a member of the Association for Professionals in Infection Control and Epidemiology (APIC), ASTM International, and the Association for the Advancement of Medical Instrumentation (AAMI). Resources From Mice to Medicine: Exploring Hantavirus and Protecting Healthcare TeamsNETEC Hantavirus InformationSBAR: Andes HantavirusNETEC Webinar Hantavirus Town Hall: Updates for Frontline StaffTransmission Interrupted PodcastNETEC Resource Library About NETEC A Partnership for Preparedness The National Emerging Special Pathogens Training and Education Center's mission is to set the gold standard for special pathogen preparedness and response across health systems in the U.S. with the goals of driving best practices, closing knowledge gaps, and developing innovative resources. Our vision is a sustainable infrastructure and culture of readiness for managing suspected and confirmed special pathogen incidents across the United States public health and health care delivery systems. For more information visit NETEC on the web at www.netec.org. NETEC Consultation Services Assess and Advance Your Readiness for Special Pathogens with Free, Expert Consulting. NETEC offers free virtual and onsite readiness consulting to help health care facilities and EMS agencies prepare for special pathogen events. Our targeted support services are delivered by experts selected and assigned to each inquiry based on the unique needs of your organization. Have a question? Ask a NETEC expert. For more information visit: netec.org/consulting-services.

This episode features Prof. Rihua Xie from Guangdong Medical University (China) and Dr. Yuhang Zhang from Peking University First Hospital (China), speaking about vaginal microbiota transfer (VMT) and how it may affect neurodevelopment in newborn infants born by Cesarean section. Compared with vaginally delivered infants, C-section delivered infants have altered microbial exposures. VMT has been proposed as a way to ‘restore' the microbiota of these infants to more closely resemble that of vaginally-born infants. A recent study by Prof. Xie and Dr. Zhang showed that the order and timing of early microbial colonization of the infant is important. They found that VMT could establish a vaginal-like skin microbiota in infants born by C-section, with two particular bacterial species that were higher after VMT. These two species led to the production of metabolites that combined on the newborn's skin to synthesize an important lipid, which was positively correlated with neurodevelopment scores at three and six months. Subsequent mouse model work showed how this lipid could reach the brain. In the future, safety and standardization of VMT will be important priorities in this research area. Prof. Xie and Dr. Zhang emphasized that their work needs to be replicated in larger cohorts, with the eventual goal of engineering bacteria to create a probiotic intervention that delivers neurodevelopmental benefits to C-section born infants. Episode abbreviations and links: The research by Prof. Xie and Dr. Zhang demonstrating how a VMT intervention alters the skin microbiota of newborns, with a mechanistic link to neurodevelopment: Vaginal microbiota transfer ameliorates cesarean-associated neurodevelopmental deficits in mice via N-bc2S1P synthesis on neonatal skin About Prof. Rihua Xie: Dr. Ri-hua Xie (RN, PhD, FAAN) is Professor, Principal Investigator, and Chief Nurse at the School of Nursing, Southern Medical University, and the Affiliated Foshan Women and Children Hospital, Guangdong Medical University, China. Dr. Xie is widely recognized for her expertise in maternal and infant health as a clinician, researcher, and supervisor. She has published more than 90 peer-reviewed papers and 11 nursing textbooks and has received 12 competitive research grants from institutions in China and Canada. In addition to her academic work, Dr. Xie is actively engaged in community and public health service, including breastfeeding promotion and frontline support during the COVID-19 pandemic. Her research focuses on perinatal epidemiology, maternal and child health, and microbiome science, with a particular emphasis on the effects of vaginal microbiota transfer (VMT) on the microbiota composition and health outcomes of cesarean-delivered infants. About Dr. Yuhang Zhang: Yuhang Zhang, PhD in Pharmacology, is an Associate Professor and Principal Investigator at Peking University First Hospital. He received his MD-PhD from Capital Medical University and was a visiting scholar at McGill University, Canada. Dr. Zhang's research focuses on gut microbiome, probiotics, and microbial metabolism in metabolic diseases, who has published over 20 peer‑reviewed papers as first or corresponding author in journals including Gastroenterology, Journal of Hepatology, and Nature Communications, cited >1,000 times. He has led 9 grants, including the National Natural Science Foundation of China, who was selected for the Beijing Association for Science and Technology Young Talent Program (2022) and the China Association for Science and Technology Young Talent Program (2025). The research of Dr. Zhang focuses on the integrated systems pharmacology, multiomics and microbiome‑host interactions to develop precision medicine.

Heat is one of the most dangerous natural hazards, causing preventable deaths and putting vulnerable communities under increasing pressure. But heat is not experienced equally, with some communities more vulnerable than others.The University of Liverpool's Melting Metropolis research is a major Wellcome funded project that explores how people experience urban heat, and how cities can respond. It brings together historians, artists, and community engagement experts to better understand heat and health in London, New York and Paris.Host Gavin Freeborn is joined in the studio by Professor Chris Pearson, Environmental Historian and Principal Investigator on the project, and Dr Anna Bocking-Welch, Senior Lecturer in History, to talk about the realities of extreme heat, and what cities need to do next. The clips are John Nairn, Senior Extreme Heat Advisor, World Meteorological Organization talking at a UN (United Nations) conference, and Dr Chloe Duteil, Melting Metropolis, University of Liverpool. More information available at liverpool.ac.uk/research/original-ideas/      

Looking for the latest research on epidermolysis bullosa (EB)?  We've got just the expert! This week, we're joined by Dr. Mercedes Gonzalez as she jumps into her team's pediatric dermatology research and their look at epidermolysis bullosa. Listen in as she discusses the historic progress in EB treatments and what that means for patients. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com. Dr. Mercedes E. Gonzalez is a board-certified pediatric dermatologist at DERM360 and Medical Director of Pediatric Skin Research in Miami, Florida. She serves as Assistant Professor of Dermatology at Florida International University Herbert Wertheim College of Medicine and the University of Miami Miller School of Medicine. A graduate of Emory University and Rutgers–New Jersey Medical School, she completed her pediatrics residency at Columbia University and dermatology and pediatric dermatology training at NYU. Dr. Gonzalez is Principal Investigator on multiple clinical trials, co-editor of three dermatology textbooks, and a Director on the American Board of Dermatology, where she chairs the several committees. Sponsored by: Chiesi Medical AffairsVisit Chiesi Medical Affairs website for more information.

A large-scale analysis of Grokipedia, the world's first AI-written encyclopedia, has found that while many Grokipedia articles closely resemble their Wikipedia counterparts, a substantial subset diverged markedly in style, sourcing, and political leaning. Conducted by researchers at Trinity College Dublin and Technological University Dublin, the study compared nearly 18,000 of the most-edited English-language Wikipedia pages with articles on the same topic on the new Grokipedia platform. The study is the largest academic analysis of Grokipedia since it was launched by Elon Musk last October with a promise that the AI-written encyclopedia systematically "fixes" left-leaning biases alleged to exist in the widely used online encyclopedia Wikipedia. Wikipedia's content is written and maintained by volunteer editors, while Grokipedia is an AI-generated encyclopedia using the xAI's Grok large language model. What did the study find? Using computational text analysis and machine learning methods, the team analysed articles on the same topic across Wikipedia and Grokipedia. Selection of topics was based on Wikipedia's most-edited English-language pages. The team compared differences in writing style, structure, and the political orientation of external sources referenced in the paired articles. The researchers found a profound split – while many Grokipedia articles closely mirror Wikipedia, a substantial proportion (66%) of the 18,000 analysed are more extensively rewritten – they are longer, more complex, and rely on fewer references. As a whole, articles on Grokipedia show similar political leaning to those on Wikipedia, drawing on left-leaning news sources. However, when it comes to the politically and culturally sensitive topics of religion, history, literature and art, Grokipedia shows a consistent shift toward referencing more right-leaning news sources compared to Wikipedia. The study analysed Wikipedia's most-edited English-language pages, a selection that likely overrepresents high-profile and contentious topics. That said the study, according to the authors, provides useful evidence of emerging differences between AI-generated and human-edited encyclopedic knowledge systems. Details of the research, conducted at the joint Centre for Sociology of Humans and Machines (SOHAM) in Trinity and TU Dublin, have been published in the peer-reviewed journal Proceedings of the National Academy of Sciences (PNAS). What is the impact of this research? Lead author of the study, Saeedeh Mohammadi, PhD candidate at SOHAM and Research Ireland's Centre for Research Training in Foundations of Data Science said: "Online encyclopedias are central to public knowledge. They are also being used to train future generations of large language models. Our findings raise important questions about how public knowledge is produce, reproduced, verified, and governed. "Unlike Wikipedia, where biases are visible and contested through human editing, AI-generated systems operate largely opaquely. This means shifts in perspective or sourcing may occur without clear accountability or editorial oversight. Simply put AI generation does not remove bias – it changes how and where bias enters the system, often making it less visible." Professor Taha Yasseri Director of SOHAM and Principal Investigator of the study said: "Rather than systematically 'correcting' Wikipedia's alleged biases, as claimed when first launched, our findings suggest that AI-generated encyclopedias such as Grokipedia selectively reshape existing knowledge. This creates a patchwork system in which some content is copied, while other content is reinterpreted in ways that are less transparent and harder to scrutinise." "There is a dire need for transparency, oversight, and regulation in this space. Our information landscape is changing rapidly. We have already seen how the lack of editorial responsibility on social media platforms has enabled the generation and circulation of misinformation and ...

In this episode in the Eco-Justice and Climate Action Mini Series, we sat down with four members of the Climate Education and Teacher Education (CETE) team, which is based at the University of Northern British Columbia. Authors of “Mapping Climate Change Education: Reflections from an Education Design-Based Research Project from Northern British Columbia, Canada,” the CETE team created this project in response to the 2022 Association of Canadian Deans of Education report titled "Accord on Education for a Sustainable Future," which underscored urgency for climate change education. Join us for another great episode exploring the stories behind this collaborative and exciting action research project!To begin, our hosts Joe and Blane introduce the CETE team and the article that brought them together [00:00]. This leads into the origin story of the initiative and discussion of their team dynamics, which lead to a shared commitment to curriculum reform and a signature pedagogy built around people, place, and land [1:57]. The conversation then explores the co-creation process at the heart of the project, from building a national design team to running iterative workshop series across northern British Columbia, reflecting on how listening to teachers and communities continuously reshaped the project's direction [7:50]. From there, the team reflects on the iterative, cyclic nature of their design-based research, and the challenges of working within research frameworks that don't always honour more-than-human species and Indigenous ways of knowing [17:03]. We move to a discussion about the tension between theory and action, and between local focus and global relevance, focusing on how grounding the work in northern land, language, and Indigenous knowledge has proven to be both their most impactful contribution and a transferable model for others [22:23]. The team closes by sharing where the project stands today, and our hosts wrap up by honouring the messiness of action research as a defining strength of the journey, not a flaw [34:04].Thank you Hartley, Christine, Alexander and Glen for sharing your time and work with us.Thank you to our listeners for tuning in to this episode of the Action Research Podcast, created by Adam Stieglitz, Joe Levitan, Shikha Diwakar, Cory Legassic, and Vanessa Gold.Produced by Shikha Diwakar and Vanja Lugonjic.Subscribe to our podcast on most major podcast distribution platforms, including Spotify and Apple Podcasts.How have you found yourself in the world of action research? Want to be interviewed or share one of your projects? Get in touch with us.Resources: CETE Research PageBiographies: Hartley Banack, University of Northern British ColumbiaDr. Hartley Banack is an Associate Professor in the School of Education at UNBC and Principal Investigator for the CETE research program since 2022. Banack is a curriculum theorist, qualitative researcher, and teacher. He has years of experience as an outdoor environmental educator and scholar. His scholarship appears in Teachers and Teaching (Banack and Tembrevilla, 2024), Children's Geographies (Banack and Berger, 2020), and Critical Education (Banack, 2018). Banack holds a Ph.D., M.A., and B.Ed. in environmental education, all from Simon Fraser University, along with a B.Sc. from Trent University.Christine Ho Younghusband, University of Northern British ColumbiaDr. Christine Ho Younghusband is an Assistant Professor in the School of Education at UNBC. Dr. Ho Younghusband is a founding CETE Co-Investigator. Her research focuses on teacher professional learning, identity development, and mathematics education. She has published on e-portfolios and identity (Younghusband, 2021) and out-of-field teaching (Younghusband, 2017). Dr. Ho Younghusband holds an Ed.D. and M.Ed. from Simon Fraser University, and B.Ed. and B.Sc. from the University of British Columbia.Alexander Lautensach, University of Northern British ColumbiaDr. Alexander Lautensach is an Adjunct Professor in the School of Education at UNBC. Lautensach is a founding CETE Co-Investigator. He holds five degrees in the areas of biology, science education, and philosophy, including a doctorate in environmental ethics education from the University of Otago, New Zealand. Lautensach has written two books on sustainability education and climate change and co-published the first open-access textbook on human security.Glen Thielmann, University of Northern British ColumbiaGlen Thielmann is a Lecturer in the UNBC School of Education. He is a founding member of the CETE Research Team. He is a master Social Studies teacher with leadership in curriculum, instruction, and professional & resource development in B.C. K-12 schools. In 2017, Glen received a Governor General's History Award for excellence in Teaching. In 2022, Glen received a Teacher Educator Award from the Association of BC Deans of Education.--This episode is part of our Eco-justice and Climate Action Series. Authors from journal articles in a Special Issue of the Canadian Journal for Action Research hop behind the mic and share the inspirations, process, and findings from their projects. Join Joe Levitan, Shikha Diwakar and special guest host Blane Harvey, as they interview an inspiring group of researchers, educators, organizers, and more, navigating the process of action research.

Co-hosts Ryan Piansky, a graduate student and patient advocate living with eosinophilic esophagitis (EoE) and eosinophilic asthma, and Holly Knotowicz, a speech-language pathologist living with EoE who serves on APFED's Health Science Advisory Council, interview Dr. Chukwuemeka Oko, MD, MBA, on clinical trials. Disclaimer: The information provided in this podcast is designed to support, not replace, the relationship between listeners and their healthcare providers. Opinions, information, and recommendations shared in this podcast are not a substitute for medical advice. Decisions related to medical care should be made with your healthcare provider. Opinions and views of guests and co-hosts are their own.   Key Takeaways: [:49] Co-host Ryan Piansky introduces this episode, brought to you thanks to the support of Education Partners GSK, Sanofi, Regeneron, and Takeda. Ryan introduces co-host Holly Knotowicz.   [1:13] Holly introduces today's topic — clinical trials — and today's guest, Dr. Chukwuemeka Oko, a Clinical Research and Medical Affairs Professional supporting Duke University Hospital's Department of Gastroenterology and Transplant Hepatology.   [1:33] Dr. Oko explains that he is sharing general, educational information from his perspective and experience, not speaking on behalf of Duke University, nor any industry sponsor, nor any company he has worked for.   [1:50] Dr. Oko's goal today is to help the listeners feel clearer, more confident, and more in control when they are thinking about clinical research.   [2:29] Dr. Oko's work sits mainly at the intersection of clinical research and medical affairs. He helps translate evolving science into practical, patient-centered decisions.   [2:40] From an academic standpoint, he supports clinical trials and evidence generation from feasibility through education.   [2:49] Dr. Oko also engages investigators and thought leaders from industry sponsors in scientific exchanges that lead to insights, study design, and real-world care pathways.   [3:03] Dr. Oko had two reasons to study eosinophilic esophagitis and eosinophilic disease. The first is the patient journey and biology.   [3:11] On the patient side, many people spend a long time seeking answers. Sometimes they feel dismissed before they get a clear diagnosis and a plan that fits their life.   [3:24] On the biology side, eosinophilic disease teaches us a lot about how our immune signals can drive information differently across tissues like the esophagus and airways.   [3:40] Dr. Oko supported an EoE study experience with an industry sponsor in the past. The best research doesn't just test; it helps patients and clinicians make clearer decisions.   [4:12] Dr. Oko explains that a clinical trial is a carefully designed, carefully crafted study in people that answers specific medical questions, most often about safety, effectiveness, or dosing of the study drug or how a treatment should be used.   [4:32] A key structure of a study is a written protocol where safety monitoring is in place, and the defined outcome or results are very reliable. The FDA always oversees clinical trials in the U.S.    [4:44] Dr. Oko often describes a trial as a highly-monitored learning system. It's how medicine moves from "We think this might help" to "We know what helps, for whom, and also at what risk."   [5:09] Dr. Oko says clinical trials usually study what improves patient outcomes, for whom, and at what risk, using methods that we can trust. Trials may evaluate new medicines, devices, dosage strategies, or even procedures.   [5:31] Clinical trials can also study non-drug approaches such as diet interventions, symptom tracking, monitoring tools, and education strategies.   [5:44] Many trials have also included biomarkers, or signals in the blood or tissue, helping to support an EoE diagnosis so that the patients can get treated in an early and effective manner.   [6:36] Dr. Oko says patients sometimes ask him if they are guinea pigs. In reality, trials are heavily regulated and closely monitored, with strict safety reporting requirements. Participants are not guinea pigs.   [7:06] Dr. Oko also hears patients ask if they are "stuck" once they join the clinical trial. No, a trial is a completely voluntary participation, and they can withdraw at any time.   [7:25] Other patients ask if trials are only for people who are out of options. Many trials are designed for earlier stages, especially when the goal is to prevent complications or reduce steroid exposure.   [7:46] The last question Dr. Oko hears a lot is "Will I be in the placebo group?" He says it's an understandable fear. They are asking if they will go untreated in the placebo group.   [8:29] In many trials, a placebo is not the same as "no care". Often, the participants continue the standard-of-care treatment, and the study drug or placebo is added to the standard-of-care treatment.   [8:45] Trials typically involve symptom monitoring and a plan for what happens if the symptoms worsen. There are exit criteria.   [9:01] From the pharmaceutical side, it's the end of treatment once you decide to voluntarily exit the study.   [9:10] Dr. Oko's advice is, if you participate, ask the study team physicians to explain in plain language what you'll receive, what you can continue, and what happens if you flare up. Clear answers are always a part of ethical research.   [10:33] Holly asks what it means to participate in a Phase 1, Phase 2, or Phase 3 trial. Dr. Oko says a Phase 1 trial is focused mostly on the safety and the dosing regimen. It's usually a small group of five to 100 or so.   [10:52] A Phase 2 trial always looks for the drug's effectiveness and continues monitoring safety. It's usually a group of 100 to 300 subjects. They look for meaningful signals of the outcomes derived from the trial.   [11:10] A Phase 3 trial is usually large. It's multi-centered. It's called a complementary study. It involves thousands of patients. It can even be across nations and states.   [11:26] This is where they compare new interventions against a placebo or against a standard of treatment to provide clinical benefits and support for regulatory approval.    [12:03] Participating in any phase of a trial includes fitting the eligibility criteria of inclusion for that particular phase. If you are a good match, you can be in either a Phase 1, Phase 2, or Phase 3 trial.   [12:52] Holly says she knows that a lot of people with EoE or EGIDs are very curious about trials and how to participate in them.   [13:00] Ryan says we have a very active patient community, and everyone's looking for ways to get involved in research and new diagnostics or medications to improve their own outcomes and help everyone else.   [13:35] Dr. Oko says the benefits of participating in a clinical trial include access to potentially disease-modifying therapies years before they reach the market.   [13:47] Another benefit is extraordinarily close medical monitoring. When you're in a clinical trial, you have more frequent visits and more frequent labs than usual.   [14:01] Endoscopies are out of the normal standard of care, but will be more frequent than normal to analyze the efficacy of the study drug.   [14:11] Dr. Oko says one of the risks is the unknown side effects the study drug comes with, because we are still understanding the biology.   [14:21] The time commitment for visits can be more than typical for a patient, especially if there is a long travel time involved. Patients may arrive at 7:00 or 8:00 a.m. They may need to find a place to live nearby, depending on the pace of the trial.   [14:57] Holly lives in Maine, and a lot of the trials are in Boston. It's a lot of travel. For people with any kind of chronic illness, all we think about is money. Holly asks if people pay to be part of a clinical trial.   [15:25] Dr. Oko states that the patients do not have to pay anything to be part of a clinical trial. Patients do get compensated by the trial sponsor for travel, accommodation, parking, and a meal for the days they are onsite.   [16:33] Dr. Oko says that patients tend to bring up insurance. It is a misconception that the study will pay for their standard-of-care medication during the study. Patients need to ask the study team what insurance will pay for and what the study will pay for.   [16:59] Dr. Oko says the insurance usually covers the regular standard-of-treatment, but any other additional treatment, procedures, and visits are all covered by the study sponsor.    [17:29] The study sponsor may ask for an endoscopy to be done six months before the study to determine eligibility for the study. If it is done within a year, the study sponsor will determine if you are qualified. That is part of the eligibility criteria in some cases.   [18:26] Dr. Oko tells patients to always ask questions, like what the schedule of events is in the clinical trial.   [18:35] The schedule of events tells you how many visits are required for you to be part of this study. They will list the activities to be done. They will list the labs you will need at what week. They will list when you need endoscopies, at week one and later.   [19:05] If you exit from the study, if you don't want to participate anymore, you are still required to come on site just to make sure that you are in good shape. Those are called formal visits.   [10:29] Dr. Oko explains that formal visits are necessary for the patient's safety and to make sure that the data points collected in the study will be effective.   [20:01] Patients enrolling in a clinical trial can also ask about the known risks of the symptom monitoring plan. They can ask what is covered and what is not covered by insurance, and what will be considered out of pocket.   [20:20] If patients are in the placebo group, what will happen if symptoms worsen? In the protocol, there is always a rescue plan. If a symptom flares up, the Principal Investigator carries out the rescue plan.   [20:58] The study team is available on a 24/7 hotline. The questions you ask are very important. No question is too small to ask. Every question and every symptom you report is important. You can withdraw at any time, and there is always a follow-up.   [22:19] Dr. Oko says the trial data that has already been collected from part of our eosinophilic studies has led to various FDA approvals of the biologics. We are working  to try to transform EoE from a steroid-dependent or diet-only disease into a position of long-term control.   [22:37] Trial findings have shaped care, expanding evidence-based options, clarifying which patients benefit the most, and improving how we measure our outcomes, the symptoms, and quality of life, as measured by patients' quality-of-life surveys.   [23:06] Quality-of-life surveys are very important for the study team. They help to measure safety, too. The evidence generated from this data leads to insights and improves study design, protocol design, and ultimately, improves patient care.   [23:40] Ryan says the community is interested in clinical trials because they benefit patients, researchers, and clinicians. We're thankful for the clinicians and researchers putting in all the work to make these clinical trials happen.   [24:01] Ryan adds, we're also thankful for the patients who are interested in these trials. For patients who are looking to participate, how can they find clinical trials to participate in and join?   [24:15] Dr. Oko says people can find the website ClinicalTrials.gov. It's an important tool in looking for various clinical research. Scientists are recruiting at a given time. You can use the Advanced Search option to narrow the search by state and criteria.   [24:54] You can always discuss clinical trials with your primary care physicians. You can look for major academic medical centers. Most of them always have clinical research studies going on.   [25:07] Dr. Oko says APFED.org is a very good tool. It always maintains up-to-date trial listings and patient-friendly summaries where patients can read about the studies.   [25:30] Ryan says he's very appreciative of the mention of APFED. There is a link on APFED.org so people can find studies. There are clinical trials listed that people can research more and join.   [25:46] Holly asks Dr. Oko to share advice for listeners who are considering participating in a clinical trial. He shares, "I want each one of you to approach the decision with the same care you would with any major medical choice. Review the Informed Consent Form (ICF)."   [26:23] "The word informed means you should be informed. It's your right to get informed with every line, every detail. The Consent Form can be 30 pages long, but please just know that you are not in a rush to answer."   [26:43] "You can take the Consent Form and discuss it with your friends, your family, your primary care physician, your gastroenterologist, and your allergist and get more information."   [27:00] "When you join an interventional trial, or a registry, your contribution accelerates the science and benefits the entire eosinophilic community."   [27:12] "From my years of reviewing medical charts and supporting new recruitments, I feel patients feel most satisfied when they are fully informed and genuinely partnered with the study team. That's how I partner with the patients. I am always there to help."    [27:40] Ryan says that is great advice for patients, and hopefully, some of our listeners to this episode will go out there and look for clinical trials to participate in or ask their physicians, next time they're getting care.   [27:52] For patients who would like to know more about eosinophilic disorders, we encourage you to visit APFED.org and check out the links in the show notes below, specifically to research opportunities listed on APFED.org. [28:08] If you've been personally impacted by eosinophilic disorders and are interested in sharing your experiences, we encourage you to please check out APFED.org/shareyourstory.   [28:17] Ryan thanks Dr.Oko for joining us today. This was really helpful and insightful, and hopefully, we'll have many new patients interested in joining clinical trials. Dr. Oko thanks Ryan and Holly for having him on and thanks every listener who has joined us.   [28:33] Dr. Oko says it has been a genuine pleasure and privilege for him. He has spent years seeing patients, reviewing their charts, and hearing their stories. We see you, we hear you. Science is advancing rapidly and shaping outcomes. You are not alone.   [30:17] Holly thanks Dr. Oko for his research and clinical trials, and thanks APFED's Education Partners GSK, Sanofi, Regeneron, and Takeda for supporting this episode.   Mentioned in This Episode:   APFED on YouTube, Twitter, Facebook, Pinterest, Instagram Real Talk: Eosinophilic Diseases Podcast Apfed.org apfed.org/specialist apfed.org/connections apfed.org/research/clinical-trials Duke University Hospital's Department of Gastroenterology Education Partners: This episode of APFED's podcast is brought to you thanks to the support of GSK, Sanofi, Regeneron, and Takeda.   Tweetables:   "Many people spend a long time seeking answers. Sometimes they feel dismissed before they get a clear diagnosis and a plan that fits their life." — Chukwuemeka Oko, MD, MBA   "On the biology side, eosinophilic disease teaches us a lot about how our immune signals can drive information differently across tissues like the esophagus and airways." — Chukwuemeka Oko, MD, MBA   "In many trials, a placebo is not the same as no care. Often, the participants continue the standard-of-care treatment, and the study drug or placebo is added to the standard-of-care treatment." — Chukwuemeka Oko, MD, MBA   "I tell patients to always ask questions, like what the schedule of events is in the clinical trial." — Chukwuemeka Oko, MD, MBA   "[If a patient exits the study], formal visits are necessary for the patient's safety and to make sure that the data points collected in the study will be effective." — Chukwuemeka Oko, MD, MBA   "From my years of reviewing medical charts and supporting new recruitments, I feel patients feel most satisfied when they are fully informed and genuinely partnered with the study team." — Chukwuemeka Oko, MD, MBA   Guest Bio: Chukwuemeka Oko, MD, MBA

Nadine Dijkstra is a Principal Investigator at the Institute of Neurology at UCL. Her research in Imaging Neuroscience explores how the brain generates mental images and differentiates them from actual perception. Utilizing neuroimaging, psychophysics, machine learning, and computational modeling, Dijkstra addresses fundamental questions about the overlap between perception and imagery.Recently, Dijkstra has been leading the Imagine Reality Lab at UCL's Department of Imaging Neuroscience, focusing on the intersection of imagination and reality. Dijkstra's 2023 paper in Nature Communications showed the brain evaluates images against a 'reality threshold' to distinguish between images and perception. Her work also investigates how changes in these neural processes could impact mental health.Check out our new series, Ideas for Our Time: https://youtu.be/nYS4FylZJ2QDon't hesitate to email us at podcast@iai.tv with your thoughts or questions on the episode!To witness such debates live buy tickets for our upcoming festival: https://howthelightgetsin.org/festivals/And visit our website for many more articles, videos, and podcasts like this one: https://iai.tv/You can find everything we referenced here: https://linktr.ee/philosophyforourtimesSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Today we are talking to Dr. John “Kip” Kramer about neuropathic pain. Dr. Kramer is a Principal Investigator and Associate Director of Operations at the International Collaboration on Repair Discoveries or iCORD at the University of British Columbia. His research interests include: Neuropathic pain, anesthesiology, MRI, Outcome measures and clinical trials. In this discussion we cover... More info: https://u2fp.org/get-educated/curecast/episode-142.html

Dr. Robert Wagner, Senior Medical Director and Principal Investigator at CTI's Clinical Research Center, shares more about clinical trial operations at research sites.  Reflecting on nearly three decades in internal medicine and hospital‑based care, Dr. Wagner shares his path from patient care into clinical research, how that experience shapes his approach as an investigator, and why strong research sites are critical to trial quality and outcomes. The conversation also touches on the day‑to‑day realities of running trials and how site operations, technology, and patient‑centered practices continue to evolve. 01:00 His past experiences and current role as a Principal Investigator at CTI.03:00 How clinical experience shaped his transition into research.05:30 Daily responsibilities and the importance of sites.08:30 Technology, recruitment, and patient access.10:45 Guidance for physicians and patients; the future of clinical research.

Liz Horn, PhD, MBI, serves as Principal Investigator of Lyme Disease Biobank, a resource that provides much-needed blood, urine, and tissue samples to researchers studying Lyme disease and other tick-borne infections. She has spent more than 2 decades working with non-profit organizations to build research initiatives and collaborations with academia, other non-profits, and industry. Since 2020, she has served as a scientific advisor for the LymeX Diagnostics Prize, a public-private partnership between the U.S. Department of Health and Human Services (HHS) and the Steven & Alexandra Cohen Foundation. Liz is passionate about building resources to move research forward that help people, improve lives, and reduce suffering. She earned her doctorate in molecular pharmacology and cancer therapeutics from SUNY at Buffalo, was a National Library of Medicine fellow in biomedical informatics, and received her MBI from Oregon Health & Science University. 

S8 E2: Character Development w/Dr. Scott Seider and Dr. Shelby ClarkIn this episode, Gerald and Alexis spoke with Dr. Scott Seider and Dr. Shelby Clark on the topic of developing character, with a context of how to develop character within schools. We dive into the key insights and lessons from their research on the topic, found in their new book: Character Compass, Second Edition: Four Directions for Building Powerful School Culture and Student Success.In this episode we dive into some insightful discussions around how we can understand character development and how we support and expand these values to young people or within a community. Summary:How are character traits defined?How do schools prioritize certain character traits?How are character traits developed in schools?How do we engage young people in conversations about character?Scott Seider is an applied developmental psychologist studying how parents and educators support young people's identity and civic development. A professor at Boston College and former Boston Public Schools teacher, he is the author of several books, including Educating for Justice (2025) and Schooling for Critical Consciousness (2020).Shelby Clark, Ph.D. (she/her) is a Principal Investigator at Project Zero and Project Director with The Good Project. Her research focuses on developing intellectual, moral, and civic character in young people—especially curiosity, open-mindedness, and social responsibility. She holds a Ph.D. from Boston University and previously worked as a school counselor in St. Paul, MN.The ReidConnect-Ed Podcast is hosted by @AlexisAnnReid and Dr. Gerald Reid, produced by @CyberSoundRecordingStudios, and original music is written and recorded by Gerald Reid (www.Jerapy.com) @MusicJerapy.*Please note that different practitioners may have different opinions- this is our perspective and is intended to educate you on what may be possible.Show notes & Transcripts: https://reidconnect.com/reid-connect-ed-podcastBe Curious. Be Open. Be Well.#character #characterdevelopment #schools #teaching#leadership #education #youthdevelopment #positiveyouthdevelopment

A lifelong smoking ban in the UK has been agreed to - but only for people born after 2008. This means that anyone born on January 1st 2009 onwards will legally not be allowed to purchase tobacco…Is this something we should replicate here? Would it be possible?Joining Shane to discuss is Dr Frank Haughton, Principal Investigator at the HEALR Research Group in Technological University of the Shannon.

Iowa continues to rank among the highest in the nation for cancer incidence, and it's one of the few states in the country where rates are still rising. What's behind the numbers?In the latest episode, Dr. Andrew Nish is joined by Mary Charleton, a professor of Epidemiology and the Director and Principal Investigator at the State Health Registry of Iowa and the Iowa Cancer Registry to break down the Cancer in Iowa Report 2026 and what it means for Iowans.

The concept of domicide and its profound impact on Homs, Syria, is explored through the work and personal experiences of architect Ammar Azzouz. A research fellow at the University of Oxford, Dr. Azzouz discusses the deliberate destruction of homes, the trauma of exile, and his eventual return to his homeland. He examines how international attention frequently prioritizes the loss of ancient heritage sites, such as Palmyra, while often overlooking the intimate grief associated with the destruction of residential areas where people lived their daily lives. The discussion also delves into the slow violence of pre-war urban projects, like the "Homs Dream", which proposed demolishing parts of the historic old city for modern development, and how these top-down models continue to threaten the city's identity during current reconstruction efforts.   01:04 Introduction 01:35 Personal Memories of Home 05:00 The Architectural Identity of Homs 06:11 Exile and Return 10:51 Domicide vs. Urbicide 13:16 Slow Violence and the Homs Dream 17:18 The Politics of Reconstruction and Dubaization 21:04 Alternative Visions for Healing 33:00 Empowering the Next Generation 34:32 The Limitations of International Heritage Organizations 41:06 Highlighting Favorite Historical Sites   Dr. Ammar Azzouz is a British Academy Research Fellow at the School of Geography and the Environment, University of Oxford. Originally from Homs, Syria, he studied architecture before moving to the UK to complete his PhD. Since leaving Syria in 2011, he has not been able to return. Dr. Azzouz is the author of Domicide: Architecture, War and the Destruction of Home in Syria (2023, Bloomsbury), with a foreword by Lyse Doucet, the BBC's Chief International Correspondent. He is the Principal Investigator of the Slow Violence and the City research project, which explores the connection between violence and the built environment in both wartime and peacetime. His current research focuses on art and culture in exile, particularly within the Syrian diaspora. Dr. Azzouz has contributed to platforms such as The New York Times, The Guardian, and The New Statesman, and has been invited to speak at over 130 events worldwide, from Mexico and the US to Germany, the Netherlands, and Qatar.   Connect with Dr. Ammar Azzouz

Among the barriers faced by researchers who move abroad to develop their careers is a so-called “hidden curriculum,” says Sonali Majumdar, whose book, Thriving as an International Scientist, was published last year.Navigating these unwritten rules that cover social norms and cultural expectations, both in the lab and outside work, can feel particularly daunting to scientists who, like her, were born elsewhere, she adds. In addition, international scientists often have restrictive funding arrangements that tie them to a particular lab or Principal Investigator's research focus, she says.US visa restrictions can often mean missing family events back home. Majumdar, for example, who gained a biochemistry and molecular biology PhD from the University of Georgia in Athena in 2014, could not return to India to attend her parents' funerals. “It was probably the biggest sacrifice I've had to make in my life,” she says. In the final episode of a six-part podcast series covering books about the scientific workplace, Majumdar, who is now assistant Dean for professional development at Princeton University in New Jersey, tells Holly Newson that having a “growth mindset” can help international scientists to thrive abroad. This means not focusing on problems, but on possibilities and solutions, she says, supported by advisors, mentors, and sponsors. The US, she says, has a reputation as a melting pot of different cultures, a place to meet colleagues with a shared passion for science and solving problems. But in the last decade the climate for researchers who relocate there from abroad has become more difficult, she adds. Hosted on Acast. See acast.com/privacy for more information.

The Rao Lab at Seattle Children's Research Institute developed a three-dimensional (3D) tissue-engineered model of osteosarcoma to investigate the effects of the extracellular matrix on malignant cell function. The study demonstrated that culturing osteosarcoma (OS) cells within a 3D collagen matrix induced unique cellular responses, altered morphology, enhanced tumorigenic behavior, and reduced chemosensitivity compared to cells cultured in 2D collagen or on standard tissue culture plastic. They identified overexpression of drug efflux pumps as a key mechanism of chemoresistance and further showed that a tyrosine kinase inhibitor could suppress drug efflux activity, thereby enhancing the efficacy of standard chemotherapeutic agents.While this earlier study examined the effects of a single collagen concentration on osteosarcoma phenotype, clinical solid tumors are characterized by altered extracellular microarchitecture, including increased matrix density and stiffness. These changes restrict drug transport and limit chemotherapy-induced cell death.Dr. Rao will present findings from engineered tumor models incorporating varying matrix densities and demonstrate how matrix density influences osteosarcoma function. This work was funded by the 2025 Outsmarting Osteosarcoma Young Investigator Hope Award.Dr. Rao is a Pediatric Hematologist Oncologist at the Seattle Children's Hospital and a Principal Investigator in the Ben Towne Center for Childhood Cancer and Blood Disorders Research at the Seattle Children's Research Institute. His lab harnesses biomaterials and tissue engineering technologies to design 3D models of osteosarcoma to understand how cell-matrix interactions lead to chemoresistance.

April 2, 2026 ~ Dr. Pooja Green, Principal Investigator SOS MATERNITY Network, Maternal Fetal Medicine Specialist, Trinity Health Ypsilanti joins Dr. Sonia Hassan in for Paul W. Smith. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Dr. Phil Wolfson offers his seasoned perspective on psychedelics, ketamine assisted therapy, and more in this expansive talk with Raghu Markus and Gagan Levy.Check out these FREE personal & clinical guidelines for use from the Ketamine Research FoundationThis week on Mindrolling, Raghu, Phil, and Gagan discuss:How psychedelics shaped Phil's worldview in the 1960s and inspired his commitment to social justiceUsing psychedelics as tools for personal growth, healing, and transformationThe importance of set and setting when taking psychedelics recreationally, therapeutically, or ceremoniously Going beyond the ups and downs of psychedelics and finding steady peace through practiceThe persistent anti-depressant effects of Ketamine and its therapeutic promisePhil's ongoing studies with the Ketamine Research Foundation for phantom limb pain, end-of-life care, and menstrual cycle disordersMind Manifesting: What exactly happens to the brain on psychedelics?Phil's ‘bottom line': positive intentions and practical guidelines for Ketamine useAbout Dr. Phil Wolfson:Phil Wolfson MD was Principal Investigator for the MAPS sponsored Phase 2, FDA approved 18-person study of MDMA Assisted Psychotherapy for individuals with significant anxiety due to life threatening illnesses. His clinical practice with ketamine has informed his leadership role in the development of Ketamine Assisted Psychotherapy. Phil's book, The Ketamine Papers, has been published by MAPS and is the seminal work in the burgeoning ketamine arena. Phil is a sixties activist, psychiatrist/psychotherapist, writer, practicing Buddhist and psychonaut who has lived in the Bay Area for 38 years. He is the author of Noe: A Father/Son Song of Love, Life, Illness and Death (2011, North Atlantic Books). He has been awarded five patents for unique herbal medicines. He is a journalist and author of numerous articles on politics, transformation, psychedelics, consciousness and spirit, and was a founding member of the Heffter Research Institute. Phil has taught in the graduate psychology programs at JFK University, CIIS and the UCSF School of Medicine Department of Psychiatry. Phil is the founder and CEO of the Ketamine Research Foundation and is committed to making the organization a vibrant contributor to the betterment of human beings through psychedelic psychotherapy."The work needs to be thought of not as a single episode, but as a therapy. Psychedelic psychotherapy is much quicker than conventional psychotherapy for many reasons, but it needs to have a follow-up, continuation, integration, and work with someone to be effective. That's not to say ketamine on its own doesn't have value, it does." – Dr. Phil WolfsonAbout Gagan Levy:Gagan Levy is the Founder/CEO of Guru, an award-winning creative agency dedicated to serving purpose-driven movements, brands, and organizations. They work with impactful brands like Patagonia, Traditional Medicinals, Nalgene, Non-GMO, The Organic Alliance, Bring Change to Mind and many natural products brands, including EO / Everyone Products, OM Mushroom Superfoods, and REBBL. Gagan also serves as Chief Evangelist at MAHA Global, a platform focused on helping businesses adapt to stakeholder needs using data-driven reputation intelligence. As former Co-chair of Social Venture Circle, one of the country's most prestigious impact investor and social business communities, Gagan leads the way to a next economy that is regenerative, just, and prosperous for all. Gagan Levy is also a current board member to his prolific teacher Ram Dass' Love Serve Remember Foundation, he has been instrumental in strategizing how to connect the greatest wisdom keepers of our time to a new generation. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

This week Clint speaks with Dr. Shawn McNeil & Dr. Donard.  In this conversation they explore the latest research and clinical practices in psychiatry, focusing on schizophrenia, genetic testing, early detection, and the impact of AI on mental health.    Dr. Shawn McNeil hosts an Apple podcast, "Addiction Medicine: Beyond the Abstract" Addiction Medicine: Beyond the Abstract - Podcast - Apple Podcasts. A quarterly, interactive addiction journal club was discussed, paired with presentation Dr. McNeil discusses on his podcast. https://podcasts.apple.com/us/podcast/addiction-medicine-beyond-the-abstract/id1806152019   Biography Dr. Shawn McNeil is a physician and researcher at LSU Health Shreveport. He is a Clinical Assistant Professor in the Department of Psychiatry and Behavioral Medicine and serves as Program Director of the Psychiatry Residency Program and Director of Neuroinformatics Research. He is a diplomate of the American Board of Psychiatry & Neurology and is board-certified in General Psychiatry and Child & Adolescent Psychiatry. He completed his Psychiatry residency at LSU Health Shreveport and is a recipient of the Resident Recognition Award from the American Psychiatric Association (APA). He also completed his fellowship in Child & Adolescent Psychiatry at LSU Health, serving as chief resident of the program.   Clinically, Dr. McNeil practices at Louisiana Behavioral Health where he serves as Chief Medical Officer. He also supervises residents at the Ochsner LSU Health Ambulatory Care Center. His primary research is clinical in nature. He is Principal Investigator on a clinical trial (Apathy in Schizophrenia, Intra-Cellular Therapies, Inc.) at the LSU Health Psychiatry Research Clinic which is investigating the use of Lumateperone on motivation in patients with psychotic disorders. He previously worked on the Blüm Autism Study (sponsored by Curemark) and the Tapestry Autism Study (sponsored by Axial Therapeutics). He is also the Director of Clinical Research for the Louisiana Addiction Research Center.   Dr. McNeil serves as President of the Louisiana Psychiatric Medical Association (LPMA). He is on the editorial board of the Journal of Addiction Medicine (JAM) and is host of their podcast "Addiction Medicine: Beyond the Abstract". He is a 2018 recipient of the ASAM's Ruth Fox Memorial Endowment Scholarship. He has also served on the editorial board of the APA's American Journal of Psychiatry Resident's Journal and he has been recognized as a Fellow of the APA.   Dr. McNeil was previously a staff physician at the Overton Brooks VA Medical Center and treated veterans in the Post-Traumatic Stress Disorder Clinic. He continues to proudly serve as a Deputy Coroner of Caddo Parish, Louisiana.     Donard Dwyer, PhD Professor of Psychiatry and Behavioral Medicine   Biography Donard Dwyer received his BS degree in Psychology from Tulane University, a Master's degree in education (MEd) from the University of Rochester and his PhD from the University of Alabama at Birmingham (UAB). In addition, to holding positions as a Research Scientist at the Max-Planck Society laboratories in Würzburg, Germany and Director of Immunology at a Cambridge biotechnology company, Dr. Dwyer has spent 32 years in academic research at UAB and LSU Health Shreveport. He is currently professor of Psychiatry and Pharmacology, Toxicology and Neuroscience at LSU Health Shreveport. In addition, he is Vice-Chair for Research in the Department of Psychiatry.   His research interests range broadly from the evolution of protein ligand-receptor interactions, the electronic properties of amino acids and regulation of glucose transport in neurons to behavioral genetics of motivation and movement in C. elegans and the genetic basis for schizophrenia and neuropsychiatric disorders. He is currently focused on the role of insulin signaling pathways in regulation of motivation in “suicidal” worms and characterization of the genetic architecture of schizophrenia with mathematical approaches. Finally, his laboratory is searching for drugs that produce neuroenhancement in cultured neurons as potential treatments for an array of neuropsychiatric conditions.     Medical Trial: https://www.lsuhs.edu/departments/school-of-medicine/psychiatry-and-behavioral-medicine/research   Chapters 00:00 Introduction to the Podcast and Guests 02:27 Overview of Schizophrenia and Motivation Challenges 04:23 The New Drug Adalumid Teparone and Its Potential 07:50 Understanding Schizophrenia: Causes and Risk Factors 12:04 Genetics of Schizophrenia: Myths and Realities 16:20 Enrolling Patients in Clinical Trials 20:49 Genetic Testing and Personalized Medicine in Psychiatry 25:54 Early Signs of Psychosis in Children 30:50 Supporting Families and Community Resources 40:04 The Role of AI in Future Psychiatry 52:17 AI and the Risks of Artificial Relationships 56:35 Conclusion: Hope and the Future of Mental Health Care

How can teacher educators build spaces “outside the system” for critical, community-engaged, and personal work? As members of our Writing & Literacies and broader AERA communities travel to LA for this year's AERA annual conference, we invite you to download this Soundcloud exclusive episode for your travel day. Joining us on this episode of Inquiring Minds are two scholars and teacher educators who live and work in the greater Los Angeles area. From California State Dominguez Hills, professors Stephanie Cariaga and Edward Curammeng discuss teacher education at the intersections of critical literacies, ethnic studies, and trauma-informed perspectives on healing. Stephanie Cariaga has served the wider Los Angeles community for about two decades as an English teacher, founding member of the People's Education Movement, and is now an associate professor in teacher education at California State University Dominguez Hills. She is the founder of CrEW — Critical Embodied Wellness for Educators — a space of refuge, restoration, and resistance that supports radical educators to teach and lead from the wisdom of their whole selves. Her teaching and research seek to reintegrate the mind, body, and spirit into classrooms and beyond to cultivate spaces of truth-feeling and healing with marginalized students and educators. She is inspired by many teachers, including Black and Brown feminist world-makers, her ancestors, CrEW co-conspirators, and most of all: her children Laila and Lino. Edward R. Curammeng (Ph.D., Education, UCLA) is an Associate Professor in the College of Education and Graduate Program Director for the MA in Education at California State University, Dominguez Hills. His teaching and research interests include Ethnic Studies Education and critical race theory in education to examine the experiences of students and teachers of color. His scholarship has been published in Review of Educational Research, Teacher Education Quarterly and Journal of Asian American Studies. Upon transferring from Ohlone College, he earned his BA and MA in Asian American Studies from San Francisco State University where he taught middle and high school Filipino American and Ethnic Studies with Pin@y Educational Partnerships. Curammeng is the Project Director and Principal Investigator for the U.S. Department of Education funded Multilingual/Minoritized Educators Networked-Learning and Development (MEND) project.

Send us Fan MailDr. Jochen Profit, Chair and Principal Investigator at CPQCC and Wendy J. Tomlin-Hess Endowed Professor of Pediatrics at Stanford Medicine, joins the podcast to discuss what truly separates high performing NICUs from the rest. He makes the case for process metrics over mortality as quality markers, highlighting normothermia on admission, breast milk feeding at discharge, and infection rates as deceptively simple yet deeply revealing indicators of unit culture. The conversation also explores how toxic work environments and provider burnout silently undermine quality improvement efforts.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below.Enjoy!

As a cultural powerhouse, the Caribbean region has the potential to become a digital leader in leveraging AI and VR technologies to preserve the region's unique identity, modernise its education systems, and ensure that digital inclusion reaches every citizen. Amanda Zilla, the Principal Investigator of the dream LAB, within the Artificial Intelligence Innovation Centre (AIIC), joins us to discuss, among other things,   *  the ways in which AI and VR can be leveraged in areas such as the arts, culture, and education;   *  how VR and AI can help Caribbean people to better engage with their own history;   *  how the dream LAB is navigating thorny issues such as copyright and cultural appropriation; and   *  how AI-enhanced VR experiences help countries further develop their tourism product beyond sea and sand.    The episode, show notes and links to some of the things mentioned during the episode can be found on the ICT Pulse Podcast Page (www.ict-pulse.com/category/podcast/)       Enjoyed the episode?  Do rate the show and leave us a review!       Also, connect with us on: Facebook – https://www.facebook.com/ICTPulse/   Instagram –  https://www.instagram.com/ictpulse/   Twitter –  https://twitter.com/ICTPulse   LinkedIn –  https://www.linkedin.com/company/3745954/admin/   Join our mailing list: http://eepurl.com/qnUtj    Music credit: The Last Word (Oui Ma Chérie), by Andy Narrell Podcast editing support:  Mayra Bonilla Lopez   ---------------

In this special re-run episode of The Crop Science Podcast Show, we bring back our conversation with Dr. Phuong Dao from Colorado State University, who shares cutting-edge insights into how remote sensing, AI, and geospatial science are transforming precision agriculture. Learn how high-resolution hyperspectral imaging and machine learning are helping detect crop issues, optimize yields, and prepare the next generation of agricultural data scientists. Listen now on all major platforms!"Remote sensing provides a non-destructive and rapid method to detect and monitor disturbances in crops."Meet the guest: Dr. Phuong Dao is an Assistant Professor at The University of Texas at Austin and Principal Investigator of the Remote Sensing and Environmental Intelligence Lab. Research focuses on integrating remote sensing, geospatial science, plant ecology, and machine learning to understand crop disturbances and plant responses. Work connects plant physiology, environmental stress, and precision agriculture technologies for improved crop monitoring. Liked this one? Don't stop now — Here's what we think you'll love!What you will learn:(00:00) Highlight(00:59) Introduction(04:19) Remote sensing use(06:04) Hyperspectral imaging(13:04) Future of ag tech(15:29) AI in crop science(18:01) Workforce development(22:52) Final three questionsThe Crop Science Podcast Show is trusted and supported by innovative companies like:- KWS

A key question about the early history of the Solar System is whether the giant planets formed roughly at the distances from the Sun they presently occupy, or, as some theories predict, much closer to the Sun. The discovery of other solar systems with radically different configurations of planets has made this question more pressing, since it appears that the configuration of the Solar System might be atypical. In the podcast, Hal Levison explains why the Trojan asteroids of Jupiter offer us the best opportunity to discriminate between the various models of Solar System evolution. And that is why a spacecraft called Lucy is now well on its way to a rendezvous with these asteroids. Hal Levison is the Principal Investigator of the Lucy mission. He studies the dynamics of astronomical objects and, in particular, the formation and long-term behavior of solar system bodies. He is one of the original proponents of the Nice model (named after the city where it was conceived), a scenario that proposes the migration of the giant planets from an initial compact configuration closer to the Sun to their present positions. He is Chief Scientist in the Department of Space Sciences at the Southwest Research Institute in Boulder, Colorado.

Today's guest is Jason Luoma, PhD. Jason is a clinical psychologist, researcher, entrepreneur, and psychotherapy trainer based in Portland, Oregon. For over two decades, Jason's research has focused on shame, stigma, and the interpersonal functions of emotion, with more recent work centered on psychedelic science. He served as Principal Investigator on one of the first MDMA-assisted psychotherapy trials in the Pacific Northwest and has contributed to multiple NIH-funded clinical trials in roles including co-investigator, consultant, therapist, and trainer.Jason is co-author of the bestselling ACT text Learning Acceptance and Commitment Therapy and Values in Therapy, and is currently writing a book on psychedelic-assisted therapy for Guilford Press. A longtime leader in the ACT community, he is a peer-reviewed ACT trainer, former president of the Association for Contextual Behavioral Science, and co-founder of several innovative organizations, including the Portland Psychotherapy Clinic, Research, & Training Center and the Portland Institute for Psychedelic Science.He also hosts The Research Matters Podcast, where he interviews leading researchers about what makes their work impactful and effective.Some of the topics we explore in this episode include:-His early development in Steve Hayes' lab-The evolution of ACT and contextual behavioral science-The need for more experiential learning for clinicians -psychedelics and their application for healing-Hopes for the future of psychedelic assisted therapy —————————————————————————Jason's Website: https://jasonluoma.com/—————————————————————————Thank you all for checking out the episode! Here are some ways to help support Mentally Flexible:You can help cover some of the costs of running the podcast by donating a cup of coffee! www.buymeacoffee.com/mentallyflexiblePlease subscribe and leave a review on Apple Podcasts. It only takes 30 seconds and plays an important role in being able to get new guests.https://podcasts.apple.com/us/podcast/mentally-flexible/id1539933988Follow the show on Instagram: https://www.instagram.com/mentallyflexible/Check out my song “Glimpse at Truth” that you hear in the intro/outro of every episode: https://tomparkes.bandcamp.com/track/glimpse-at-truthCheck out my new album, Holding Space! https://open.spotify.com/album/0iOcjZQhmAhYtjjq3CTpwQ?si=nemiLnELTsGGExjfy8B6iw

One of the most exciting missions to ever journey to the outer solar system has the be the Dragonfly multi-rotor helicopter that will head to Saturn's moon Titan in 2028. The car-sized probe will arrive at that strange, frozen world in 2034, descending into the soupy, smoggy atmosphere and then taking flight before it even touches the ground! We spoke with the mission's Principal Investigator, Dr. Elizabeth "Zibi" Turtle, about the mission's origins, current progress, and what to expect in the coming years. She also took us through a narrated tour of the surface of Titan, with its hydrocarbon sand dunes and methane seas. The Dragonfly mission will be an adventure of a lifetime! Headlines: NASA's Artemis II Moon Rocket Aces New Fueling Test Boeing Starliner is Rated a "Type A" Mishap and Faces More Launch Delays Perseverance Rover Gets Instant Mars GPS-like Functionality Main Topic: NASA's Dragonfly Mission to Titan Dr. Elizabeth Turtle explains Dragonfly's origins and mission concept Why Titan is unique and somewhat akin to the primordial Earth, perfect for exploring prebiotic chemistry Dragonfly's advanced science suite and autonomous flying capability Insights from the Cassini/Huygens missions and how they are shaping Dragonfly Navigation, flight strategy, and safety planning for Titan's harsh environment Power, heating, and longevity on Titan's freezing surface Titan's dune landscape, flying conditions, and analogs to Earth Big scientific questions: methane cycle, atmospheric mysteries, and potential surprises Mission timeline, lander design, and the innovative "fly-as-you-land" arrival approach Hosts: Rod Pyle and Tariq Malik Guest: Dr. Elizabeth Turtle Download or subscribe to This Week in Space at https://twit.tv/shows/this-week-in-space. Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free audio and video feeds, a members-only Discord, and exclusive content. Join today: https://twit.tv/clubtwit

Kristof interviews Dr. Sarah HainesThe Indoor Microbiome is the complex, invisible world of microorganisms living within our daily surroundings, serving as the primary ecological interface through which buildings influence human biology. In this light, we are beginning to view indoor environments not merely as passive shelters, but as powerful positive health interventions that can actively shape our immune development and long-term wellbeing.Today, we are joined by Dr. Sarah Haines, Assistant Professor at the University of Toronto and Principal Investigator of the IMEE Lab, to explore the foundational framework behind this shift. We will discuss the emerging perspective of "biologically informed architectural design" and the fact that architects and interior designers don't just curate materials, they curate our basic microbial exposures and therefore our health and wellbeing. Sarah HainesProfessor Sarah Haines' interdisciplinary research integrates building science, engineering, and microbiology to analyze the impact the built environment has on human health. She uses cutting-edge microbiology techniques such as next-generation sequencing, metatranscriptomics, and bioinformatics to understand the impact of moisture on indoor environmental quality. Linking to climate change, her research explores the impact of weatherization and extreme weather events on indoor air quality, particularly in low income communities who may be at a higher risk for asthma. Her work aids in understanding indoor exposures from microorganisms and chemicals providing for a cleaner and sustainable indoor environment.TeamHosted by Kristof IrwinEdited by Nico MignardiProduced by M. Walker

While the Roman Empire conquered much of western Europe and established a powerful presence in Britain, Ireland remained beyond its grasp. But why? In this episode, I am joined by Dr Jacqueline Cahill Wilson to explore how Ireland interacted with the Roman world. It is a complex and intriguing story. Jacqueline reveals the considerable archaeological evidence that suggests Roman communities did exist in Ireland. If there was no invasion, however, this raises an obvious question: who were these people, why did they come to Ireland, and what were they doing there? Sound by Kate Dunlea. My guest on this episode is Dr Jacqueline Cahill Wilson. Originally from County Longford, she is a Research Fellow at the Royal Agricultural University in Cirencester. She holds an MA from the University of Reading and a PhD from the University of Bristol. From 2011 to 2015, she served first as Principal Investigator and later as Project Director of a major research project with the Discovery Programme in Dublin titled Late Iron Age and Roman Ireland. Her research focuses on social structures and identity in the past, and on how communities defined themselves and others through material evidence in the archaeological record. A key part of her work has involved the use of isotope geochemistry on human burials in Ireland, allowing researchers to identify where individuals originated from and challenging long held assumptions about identity and mobility in the past. Her work has consistently explored the interconnectedness of Ireland in its Iron Age with Britain and Europe under Roman control, periods that are often studied separately despite unfolding at the same time. She is currently working on a book titled Within or Without: Ireland in the Roman World, which brings together her doctoral research, the Discovery Programme project, and her subsequent research into a new historical study for a general readership. Hosted on Acast. See acast.com/privacy for more information.